Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2019

Open Access 01.12.2019 | Research article

Short-term results of bilateral internal mammary arterial grafting for patients aged 60–75 years – a retrospective study

verfasst von: Yilong Guo, Xiaoqi Wang, Shuwu He, Yue Shu, Tianguang Wang, Zelun Chen

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2019

Abstract

Background

Bilateral internal mammary artery (BIMA) grafting has a good long-term survival rate and graft patency rate, but it is only recommended in young patients due to its high technical requirements and high incidence of sternal complications. Previous studies indicated that BIMA grafting has a significant benefit in patients aged 50–59 years, but this benefit does not extend to patients aged > 60 years. Thus, this study was designed to analyse the immediate artery graft function, short-term (3 months) results, and experience in preventing sternal complications for BIMA grafting in elderly patients (60–75 years old).

Methods

Clinical records and echocardiographic and coronary artery computed tomography angiography data of 155 patients who underwent BIMA grafting for coronary artery disease between 2015 and 2017 in our hospital were analysed retrospectively to summarise the operative experience and short-term (3 months) results. Patients were divided into two groups: Group A (n = 95), aged < 60 years and Group B (n = 60), aged 60–75 years. The operation time, aortic clamp time, and cardiopulmonary bypass time of these two groups were compared to analyse the operation difficulty and the flow and pulsatility index were compared to analyse the immediate artery graft function. The left ventricular end-diastolic dimension (LVEDD) and left ventricular ejection fraction (LVEF) of these two groups were compared to analyse heart function.

Results

There were no significant differences in the operation time, aortic clamp time, and cardiopulmonary bypass time as well as the flow and pulsatility index between these two groups (P > 0.05). There was no significant difference in the incidence of sternal wound complications, graft occlusion, and other common complications 3 months post-BIMA grafting between these two groups (P > 0.05). Furthermore, there was no significant difference in LVEDD and LVEF between the groups 3 months post-operation (P > 0.05).

Conclusions

BIMA grafting was safe and effective for older patients (60–75 years). Similar to younger patients (< 60 years), BIMA grafting in elderly patients (60–75 years) can also achieve a satisfactory short-term (3 months) result. Thus, advanced age (60–75 years) should not be a contraindication for BIMA grafting.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BIMA
Bilateral internal mammary artery
BMI
Body mass index
CABG
Coronary artery bypass grafting
COPD
Chronic obstructive respiratory dysfunction
CPB
Cardiopulmonary bypass
CTA
Computed tomography angiography
HbA1c
Glycated haemoglobin A1c
IMA
Internal mammary artery
LAD
Left anterior descending branch
LIMA
Left internal mammary artery
LVEDD
Left ventricular end-diastolic dimension
LVEF
Left ventricular ejection fraction
NYHA
New York Heart Association
OM
Obtuse marginal branch
PI
Pulsatility index
RIMA
Right internal mammary artery
SD
Standard deviation
SIMA
Single internal mammary artery

Background

With increasing global life expectancy and the aging population, the proportion of coronary artery bypass grafting (CABG) for elderly patients is increasing [1]. In recent years, an increasing number of scholars have focused their attention on total arterialized CABG due to its excellent patient survival rate [2, 3]. The reason for that is the high patency rate of arterial grafts, as well as the protective effect of arterial grafts on the coronary circulation of the patients [4]. At present, a large number of studies have shown that BIMA grafting is superior to single internal mammary artery (SIMA) grafting in cardiac function protection and long-term survival after surgery [5, 6]. However, due to the long operation time, high technical requirements, and high incidence rate of sternal wound complications, the application of BIMA grafting is limited [7]. At present, the application rate of BIMA grafting is about 5% worldwide, and it is only recommended for younger patients [8]. Mohammadi et al. reported that BIMA grafting has significant benefit in patients aged 50–59 years, but this benefit does not extend to patients aged > 60 years [9]. Thus, this study was designed to analyse the operation experiences, immediate artery graft function, short-term results, and experience in preventing sternal complications of BIMA grafting in elderly patients (60–75 years old).

Methods

Patients

From December 2015 to August 2017, 185 patients with coronary artery disease underwent BIMA grafting in our hospital. The inclusion criteria were as follows: patients with left main coronary artery plus triple-vessel disease or only triple-vessel disease. The exclusion criteria were as follows: 1) emergency surgery or patients with other severe cardiac diseases requiring concurrent surgery; 2) patients with severe heart failure or multiple organ dysfunction before the operation; and 3) preoperative computed tomography angiography (CTA) showing proximal subclavian artery or internal mammary artery stenosis. Finally, 155 patients were included in this retrospective study. The patients were divided into two groups: Group A included 95 patients, aged < 60 years and Group B included 60 patients, aged 60–75 years.

Operative methods

All the surgeries were performed by a single surgeon. The surgeries were performed via median sternotomy. The BIMA and great saphenous vein were harvested initially. In 39 patients of Group A and 25 of Group B, the internal mammary artery (IMA) was harvested with the skeletonization technique (Fig. 1). There were no significant differences in the IMA harvesting technique between these two groups (P = 0.94). After the IMA was freed completely, it was heparinised, and the distal end of the vessel was cut off. Then, it was wrapped in papaverine wet gauze for preservation. All of the surgeries were performed under cardiopulmonary bypass (CPB), mild hypothermia, and cardioplegic arrest. Ice water was placed in the pericardial cavity after cardiac arrest. The distal end of the graft was anastomosed initially, and then the proximal end of the graft was anastomosed after aortic unclamping. If the length of the IMA was insufficient, it was used as a free graft. The common grafting paths were as follows: the right internal mammary artery (RIMA) was anastomosed to the left anterior descending artery (LAD) across the midline (Fig. 2) or to the high obtuse marginal branch artery (OM) through the transverse sinus (Fig. 3); Sometimes, the RIMA was anastomosed to the right coronary artery (RCA); the left internal mammary artery (LIMA) was anastomosed to the diagonal branch artery, OM, or LAD; and the great saphenous vein was anastomosed to the posterior descending artery, left ventricular posterior artery, or OM. In Group A, all LIMAs were in situ grafts, while eight RIMAs were free grafts. Four of them were anastomosed to the LAD, and the other four to the high OM (Fig. 4). In Group B, all LIMAs were in situ grafts, while four RIMAs were free grafts; three of them were anastomosed to the high OM, and one to the RCA. The pathway of arterial grafts is shown in Table 1.
Table 1
Pathway and patency of arterial grafts
 
Group A (n = 95)
Group B (n = 60)
Case
Occlusion (3 months post-operation)
Case
Occlusion (3 months post-operation)
LIMA
 LIMA-OM
51
1
41
 LIMA-D
32
12
 LIMA-LAD
12
7
RIMA
 RIMA-LAD
77
1
52
1
 RIMA-OM
11
7
 RIMA-RCA
7
1
LIMA left internal mammary artery, OM obtuse marginal branch artery, D diagonal branch artery, LAD left anterior descending artery, RIMA right internal mammary artery, RCA right coronary artery

Postoperative medication treatment

Patients without risk of bleeding were routinely treated with aspirin plus clopidogrel for 1 year after surgery, and then only with aspirin. Lipid-lowering, blood pressure control, heart rate control, and coronary artery dilatation were prescribed routinely unless they had contraindications. Echocardiography and coronary CTA were performed 3 months post-operation.

Data collection and processing

Preoperative data collected included the sex ratio, age, body mass index (BMI), diabetes, hypertension, hyperlipidaemia, previous myocardial infraction, serum creatinine, peripheral artery stenosis, preoperative glycated haemoglobin A1c (HbA1c), cardiac function (New York Heart Association, NYHA, grade), left ventricular end-diastolic dimension (LVEDD), and left ventricular ejection fraction (LVEF). The operative time, aortic clamp time, CPB time, number of distal coronary anastomosis, flow rate and pulsatility index (PI) value of the LIMA and RIMA, and early postoperative complications were also collected. The flow rate and PI value of the IMA graft were measured by Veri Q system (Medistim, Sandakervn, Norway) under the condition of 60 mmHg mean arterial pressure and the anastomosis was completed. Patency of graft, LVEDD, and LVEF were measured in every patient with Doppler echocardiography and coronary artery CTA at 3 months after operation.
Mild sternal wound complications referred to delayed healing and sternal wound exudation without sternal loosening or wound infection. It could be cured by simple treatment, such as dressing change and local pressure without sternum re-fix and debridement. Severe sternal wound complications referred to sternum loosening or wound infection, which can only be cured by sternum re-fixation and wound debridement.

Statistical analysis

Data were expressed as mean ± standard deviation (SD) or percentages of patients. Between-group comparisons of patient characteristics and intraoperative and postoperative variables were performed by the Chi-square test, Fisher’s exact test, Student’s t-test, or Mann-Whitney U test, as appropriate. All statistical data were analysed using SPSS 19.0 (IBM Inc., Armonk, NY), and P < 0.05 was considered statistically significant.

Results

Characteristics of the study population

There were 95 patients in Group A, the youngest of whom was 25 years old, with an average age of 52.08 ± 6.103 years. There were 60 patients in Group B, the oldest of whom was 75 years old, with an average age of 63.10 ± 3.112 years. The mean age of group B was significantly higher than that of Group A (P < 0.01). The incidence rate of diabetes and peripheral artery stenosis in group B was significantly higher than that in Group A (P = 0.002, 0.011). There were no significant differences in the sex ratio, BMI, hypertension, hyperlipidaemia, previous myocardial infraction, preoperative HbA1c, serum creatinine, preoperative cardiac function (NYHA), LVEDD, or LVEF between the groups. The characteristics of the study population are shown in Table 2.
Table 2
Characteristics of the Study Population
 
Group A (n = 95)
Group B (n = 60)
P value
Female sex
13 (13.7%)
13 (21.7%)
0.195
Mean age ± SD, y
52.08 ± 6.103
63.10 ± 3.112
< 0.01
BMI (kg/m2)
26.12 ± 3.065
25.96 ± 2.656
0.745
Diabetes
28 (29.5%)
33 (55.0%)
0.002
Hypertension
55 (57.9%)
42 (70.0%)
0.129
Hyperlipidaemia
64 (67.4%)
36 (60.0%)
0.350
Previous myocardial infraction
35 (36.8%)
19 (31.7%)
0.510
Serum creatinine (μmol/L)
80.15 ± 13.40
82.31 ± 16.83
0.379
LVEDD (mm)
42.19 ± 4.879
48.88 ± 5.717
0.787
LVEF (%)
60.79 ± 5.630
60.77 ± 7.249
0.983
Cardiac function (NYHA)
  
0.188
 I
20
9
 II
65
41
 III
10
10
Peripheral artery stenosis
15 (15.8%)
20 (33.3%)
0.011
Preoperative HbA1c(%)
6.15 ± 0.54
6.19 ± 0.51
0.673
LVEDD left ventricular end-diastolic dimension, LVEF left ventricular ejection fraction, BMI body mass index, NYHA New York Heart Association, HbA1c glycated haemoglobin A1c

Intra-operative data

No significant difference could be found in the operative time, aortic clamp time, and CPB time between the groups (P > 0.05). There was no significant difference in the number of distal coronary anastomosis between Groups A and B (P = 0.896). The flow and PI value of LIMA were 28.63 ± 13.475 ml/min and 2.25 ± 0.459, while they were 30.12 ± 13.079 ml/min and 2.14 ± 0.475 for RIMA, respectively. There were also no significant differences in the flow and PI value of LIMA and RIMA between groups (P > 0.05). The intra-operative data of the study population are shown in Table 3.
Table 3
Intra-operative data of the Study Population
 
Group A
Group B
P value
Operation time (h)
4.95 ± 0.622
4.92 ± 0.535
0.758
Aortic clamp time (min)
77.03 ± 18.135
77.47 ± 21.913
0.894
CPB time (min)
106.46 ± 23.573
107.88 ± 26.314
0.727
Number of distal coronary anastomosis
4.28 ± 0.821
4.27 ± 0.800
0.896
LIMA
 Flow (ml/min)
28.63 ± 13.475
28.25 ± 12.060
0.858
 PI value
2.25 ± 0.459
2.18 ± 0.510
0.356
RIMA
 Flow (ml/min)
30.12 ± 13.079
26.80 ± 9.359
0.900
 PI value
2.14 ± 0.475
2.16 ± 0.612
0.831
CPB time cardiopulmonary bypass time, IMA internal mammary artery, PI pulsatility index

Short-term complications

After 3 months of follow-up, the operative mortality of both groups was zero, and there was no significant difference in bleeding requiring re-exploration, drainage volume on the day of operation, chylothorax, LVEF, and LVEDD between the groups (P > 0.05). There were two mild sternal wound complications in Group A but no severe sternal wound complication. There were three mild sternal wound complications and one severe sternal wound complication in Group B. There was no significant difference in the sternal wound complication between the groups (P > 0.05). After the 3-month follow-up, there were three venous graft occlusions in Group A and two in Group B. There were two arterials graft occlusions in Group A and one in Group B. There was no repeated CABG in both Groups A and B. The arterial graft occlusions in Group A were LIMA-OM and RIMA-LAD. The arterial graft occlusion in group B was RIMA-LAD. There was no significant difference in patency of grafts between the groups (P = 0.952, 0.847). The patency of arterial grafts is shown in Table 1. The other short-term complications of the study population are shown in Table 4.
Table 4
Short-term complications of the Study Population
 
Group A (n = 95)
Group B (n = 60)
P value
Bleeding requiring re-exploration
1
0
0.425
Drainage volume on the day of operation (ml)
512.53 ± 246.71
493.67 ± 216.96
0.628
Chylothorax
3
4
0.306
Death
0
0
Sternal wound complication
 Mild
2
3
0.320
 Severe
0
1
0.207
Patency of graft (3 months after operation)
 Venous graft occlusion
3
2
0.952
 Arterial graft occlusion
2
1
0.847
 Repeated CABG
0
0
Echocardiography characteristics (3-month after operation)
 LVEF (%)
60.60 ± 5.320
59.17 ± 5.901
0.119
 LVEDD (mm)
46.62 ± 5.147
45.97 ± 4.902
0.434
CABG coronary artery bypass grafting

Discussion

The main findings of this study were: 1) no significant differences were observed in the operation time, aortic clamp time, and CPB time between Groups A and B, so there was no significant difference in the difficulty of operation between these two groups; 2) there was no significant difference in the flow and PI index of arterial grafts of LIMA and RIMA between Groups A and B; thus, there was no significant difference in the immediate artery graft function between these two groups; and 3) there was no significant difference in the incidence rate of common complications, such as graft occlusion and sternal wound complications, between these two groups at 3 months post-operation.

Operation experience

In this study, the skeletonized technique was preferred to be used in IMA harvesting and BIMA grafting was performed with extracorporeal circulation. In situ graft is recommended to reduce the risk of bleeding and the difficulty of operation, but if the length of arterial graft is insufficient, a free graft should be considered. Regarding the choice of graft for LAD, whether LIMA or RIMA, there is no literature to show the difference. We suggest that the length of graft and the extent of coronary artery lesions should be considered comprehensively in the selection of graft. Since the LIMA is closer to the left coronary system, it can provide a suitable length for the vascularization of the left coronary system; thus, the LIMA should be anastomosed to the circumflex artery or the diagonal branch artery if possible. In contrast, since RIMA is some distance from the left coronary system, it is often limited in length in the vascularization of the left coronary system; thus, it is mostly anastomosed to LAD, and sometimes it can be anastomosed to the high OM through the transverse sinus if necessary.

Experience in preventing sternal complications

At present, the main factors which limit the application of BIMA grafting are poor sternal wound healing and deep sternal wound infection, especially for elderly women, patients with BMI > 40 kg/m2, patients with severe chronic obstructive respiratory dysfunction (COPD) or poor blood sugar control [10]. In this study, the incidence rate of mild sternal wound complications was 2.1% in Group A and 5% in Group B. The incidence rate of severe sternal wound complications was 0% in Group A and 1.7% in Group B. Although the prevalence of diabetes in Group B was higher than that in Group A, there was no significant difference in the incidence rate of sternal wound complications between these two groups, and the incidence rate of severe sternal wound complications was lower than 2.3–12.8% reported in the literature [11, 12]. Our experience in the prevention of sternal wound complications was as follows. 1) For diabetic patients, blood sugar should be strictly controlled during the perioperative period; particularly, preoperative HbA1c should be controlled below 6.5%. Previous studies have shown that elevated glycosylated haemoglobin was a high-risk factor for incision complications in cardiac surgery [13]. 2) The IMA harvested with the skeletonization technique was preferred as it inflicts little damage to the chest wall, and retains the branches of the IMA and internal mammary vein. It was beneficial to both the healing of sternal wound and venous reflux [14]. Therefore, in BIMA grafting, a number of guidelines have explicitly recommended the use of the skeletonization technique to harvest the IMA to reduce the incidence rate of sternal wound complications [15, 16]. Harvesting of the IMA using the skeletonization technique required precision and strictly abided by the principle of ‘no touch,’ paying careful attention to avoid arterial spasm and endothelial injury, as it was close to the main trunk of the IMA. 3) Commonly, the sternum was fixed by the “8-shaped method”. Five steel wires were used to fix the sternum in patients who weighed less than 50 kg. For patients who weighed more than 50 kg, one additional steel wire was added for every 10 kg increase in body weight. 4) Previous studies have shown that patients with a BMI > 40 kg/m2 had a high-risk for deep sternal wound complications in BIMA grafting [10], so attention should be paid to body weight. In this study, the maximum BMI of Group A was 38.06 kg/m2, with an average BMI of 26.12 ± 3.065 kg/m2, while that of Group B was 31.91 kg/m2, with an average BMI of 25.96 ± 2.656 kg/m2. The BMI of both groups was less than 40 kg/m2, and there was no significant difference between them.
This study has some limitations: 1) This was a retrospective, non-randomised study with no multivariate analysis therefore, a certain selection bias exists. Further prospective, randomised, large-scale, long-term studies with multivariate analysis are required to validate our findings. 2) The BMI of the study patients was lower than 40 kg/m2, so further studies are needed to confirm the role of BMI > 40 kg/m2 in the occurrence of sternal wound complications.

Conclusions

BIMA grafting was safe and effective for older patients (60–75 years). Similar to younger patients (< 60 years), BIMA grafting in elderly patients (60–75 years) could also achieve a satisfactory short-term (3 months) result. Thus, advanced age (60–75 years old) should not be a contraindication for BIMA grafting.

Acknowledgements

Not applicable.
This study was approved by the Hainan Medical University Clinic Institutional Review board, and the need for patient consent was waived due to the retrospective study design.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Itoh S, Kimura N, Adachi H, Yamaguchi A. Is bilateral internal mammary arterial grafting beneficial for patients aged 75 or older? Circ J. 2016;80:1756–63.CrossRef Itoh S, Kimura N, Adachi H, Yamaguchi A. Is bilateral internal mammary arterial grafting beneficial for patients aged 75 or older? Circ J. 2016;80:1756–63.CrossRef
2.
Zurück zum Zitat Buxton BF, Shi WY, Tatoulis J, Fuller JA, Rosalion A, Hayward PA. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014;148:1238–43.CrossRef Buxton BF, Shi WY, Tatoulis J, Fuller JA, Rosalion A, Hayward PA. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014;148:1238–43.CrossRef
3.
Zurück zum Zitat Locker C, Schaff HV, Dearani JA, Joyce LD, Park SJ, Burkhart HM, et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation. 2012;126:1023–30.CrossRef Locker C, Schaff HV, Dearani JA, Joyce LD, Park SJ, Burkhart HM, et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation. 2012;126:1023–30.CrossRef
4.
Zurück zum Zitat Dimitrova KR, Hoffman DM, Geller CM, Dincheva G, Ko W, Tranbaugh RF. Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg. 2012;94:475–81.CrossRef Dimitrova KR, Hoffman DM, Geller CM, Dincheva G, Ko W, Tranbaugh RF. Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg. 2012;94:475–81.CrossRef
5.
Zurück zum Zitat Kelly R, Buth KJ, Légaré JF. Bilateral internal thoracic artery grafting is superior to other forms of multiple arterial grafting in providing survival benefit after coronary bypass surgery. J Thorac Cardiovasc Surg. 2012;144:1408–15.CrossRef Kelly R, Buth KJ, Légaré JF. Bilateral internal thoracic artery grafting is superior to other forms of multiple arterial grafting in providing survival benefit after coronary bypass surgery. J Thorac Cardiovasc Surg. 2012;144:1408–15.CrossRef
6.
Zurück zum Zitat Shi WY, Hayward PA, Tatoulis J, Rosalion A, Newcomb AE, Fuller JA, et al. Are all forms of total arterial revascularization equal? A comparison of single versus bilateral internal thoracic artery grafting strategies. J Thorac Cardiovasc Surg. 2015;150:1526–33.CrossRef Shi WY, Hayward PA, Tatoulis J, Rosalion A, Newcomb AE, Fuller JA, et al. Are all forms of total arterial revascularization equal? A comparison of single versus bilateral internal thoracic artery grafting strategies. J Thorac Cardiovasc Surg. 2015;150:1526–33.CrossRef
7.
Zurück zum Zitat Kieser TM, Lewin AM, Graham MM, Martin BJ, Galbraith PD, Rabi DM, et al. Outcomes associated with bilateral internal thoracic artery grafting: the importance of age. Ann Thorac Surg. 2011;92:1269–75.CrossRef Kieser TM, Lewin AM, Graham MM, Martin BJ, Galbraith PD, Rabi DM, et al. Outcomes associated with bilateral internal thoracic artery grafting: the importance of age. Ann Thorac Surg. 2011;92:1269–75.CrossRef
8.
Zurück zum Zitat Itagaki S, Cavallaro P, Adams D, Chikwe J. Bilateral internal mammary artery grafts, mortality and morbidity: an analysis of 1526360 coronary bypass operations. Heart. 2013;99:849–53.CrossRef Itagaki S, Cavallaro P, Adams D, Chikwe J. Bilateral internal mammary artery grafts, mortality and morbidity: an analysis of 1526360 coronary bypass operations. Heart. 2013;99:849–53.CrossRef
9.
Zurück zum Zitat Mohammadi S, Dagenais F, Doyle D, Mathieu P, Baillot R, Charbonneau E, et al. Age cut-off for the loss of benefit from bilateral internal thoracic artery grafting. Eur J Cardiothoracic Surg. 2008;33:977–82.CrossRef Mohammadi S, Dagenais F, Doyle D, Mathieu P, Baillot R, Charbonneau E, et al. Age cut-off for the loss of benefit from bilateral internal thoracic artery grafting. Eur J Cardiothoracic Surg. 2008;33:977–82.CrossRef
10.
Zurück zum Zitat Pettinari M, Sergeant P, Meuris B. Bilateral internal thoracic artery grafting increases long-term survival in elderly patients. Eur J Cardiothorac Surg. 2015;47:703–9.CrossRef Pettinari M, Sergeant P, Meuris B. Bilateral internal thoracic artery grafting increases long-term survival in elderly patients. Eur J Cardiothorac Surg. 2015;47:703–9.CrossRef
11.
Zurück zum Zitat Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Pawlaczyk R, et al. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: insights from the arterial revascularization trial. J Thorac Cardiovasc Surg. 2016;152:270–6.CrossRef Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Pawlaczyk R, et al. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: insights from the arterial revascularization trial. J Thorac Cardiovasc Surg. 2016;152:270–6.CrossRef
12.
Zurück zum Zitat Deutsch O, Gansera L, Wunderlich M, Eichinger W, Gansera B. Does bilateral ITA grafting increase perioperative complications? Outcome of 6476 patients with bilateral versus 5020 patients with single ITA bypass. Thorac Cardiovasc Surg. 2016;64:188–94.CrossRef Deutsch O, Gansera L, Wunderlich M, Eichinger W, Gansera B. Does bilateral ITA grafting increase perioperative complications? Outcome of 6476 patients with bilateral versus 5020 patients with single ITA bypass. Thorac Cardiovasc Surg. 2016;64:188–94.CrossRef
13.
Zurück zum Zitat Rollins KE, Varadhan KK, Dhatariya K, Lobo DN. Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. Clin Nutr. 2016;35:308–16.CrossRef Rollins KE, Varadhan KK, Dhatariya K, Lobo DN. Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. Clin Nutr. 2016;35:308–16.CrossRef
14.
Zurück zum Zitat Kamiya H, Akhyari P, Martens A, Karck M, Haverich A, Lichtenberg A. Sternal microcirculation after skeletonized versus pedicled harvesting of the internal thoracic artery: a randomized study. J Thorac Cardiovasc Surg. 2008;135:32–7.CrossRef Kamiya H, Akhyari P, Martens A, Karck M, Haverich A, Lichtenberg A. Sternal microcirculation after skeletonized versus pedicled harvesting of the internal thoracic artery: a randomized study. J Thorac Cardiovasc Surg. 2008;135:32–7.CrossRef
15.
Zurück zum Zitat Gatti G, Maschietto L, Morosin M, Russo M, Benussi B, Forti G, et al. Routine use of bilateral internal thoracic artery grafting in women: a risk factor analysis for poor outcomes. Cardiocasc revasc Med. 2017;18:40–6.CrossRef Gatti G, Maschietto L, Morosin M, Russo M, Benussi B, Forti G, et al. Routine use of bilateral internal thoracic artery grafting in women: a risk factor analysis for poor outcomes. Cardiocasc revasc Med. 2017;18:40–6.CrossRef
16.
Zurück zum Zitat Hashimoto M, Fukui T, Takanashi S. Bilateral Internal Thoracic Artery Grafting: Is It Reasonable in Octogenarians? Ann Thorac Cardiovasc Surg. 2015;21:452–8.CrossRef Hashimoto M, Fukui T, Takanashi S. Bilateral Internal Thoracic Artery Grafting: Is It Reasonable in Octogenarians? Ann Thorac Cardiovasc Surg. 2015;21:452–8.CrossRef
Metadaten
Titel
Short-term results of bilateral internal mammary arterial grafting for patients aged 60–75 years – a retrospective study
verfasst von
Yilong Guo
Xiaoqi Wang
Shuwu He
Yue Shu
Tianguang Wang
Zelun Chen
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2019
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-019-1006-8

Weitere Artikel der Ausgabe 1/2019

Journal of Cardiothoracic Surgery 1/2019 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.